SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about company updates

16 Dec 2016 Evaluate

Anuh Pharma has informed that the inspection of manufacturing site of Anuh Pharma at E-17/3 and E-17/4, M.I.D.C. Tarapur, Taluka Palghar, District Thane 401506, Boisar, Maharashtra, India on September 16, 2016 by French Naional Agency for Medicines and Health Products Safety (ANSM) for the Erythromycin Ethyl Succinate and Pyrazinamide. Considers the site in compliance with principles of GMP for active substances referred to in Article 47 of Directive 2001/83/EC and has granted EUGMP Certificate for the above mentioned products.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma Share Price

84.15 1.20 (1.45%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×